Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Subject-Blind, Investigator-Blind, Placebo-Controlled, Single-Dose, Dose-Escalating Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of UCB0159 in Subjects With Mild to Moderate Psoriasis, and Single-Dose Pharmacokinetics and Safety in Healthy Subjects

NCT07849894 is registered in ClinicalTrials.gov with UCB Biopharma SRL as lead sponsor.

NCT NCT07849894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07849894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Subject-Blind, Investigator-Blind, Placebo-Controlled, Single-Dose, Dose-Escalating Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of UCB0159 in Subjects With Mild to Moderate Psoriasis, and Single-Dose Pharmacokinetics and Safety in Healthy Subjects
Lead sponsor
UCB Biopharma SRL
Phase
Phase 1
Overall status
Completed
Start date
June 23, 2017
Completion date
December 8, 2018
Enrollment
54 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers, mild to moderate psoriasis